OSAKA - Medical startup Anges Inc. said Thursday it will soon start Japan's first clinical test on humans of a potential vaccine for the new coronavirus, after gaining formal approval from an Osaka City University Hospital committee.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
